Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jaime Jimenez
The USER Study: A Chart Review of Patients Receiving a 0.2 Μg/Day Fluocinolone Acetonide Implant for Diabetic Macular Edema
Ophthalmology and Therapy
Ophthalmology
Related publications
Real-World Experience of Fluocinolone Acetonide (0.2 Μg/Day) Intravitreal Implant in the Treatment of Diabetic Macular Oedema
European Ophthalmic Review
Efficacy and Safety of Corticosteroid Implant (Fluocinolone Acetonide (FAc) 0.2 Μ G/Day, Iluvien ® ) for Management of Diabetic Macular Edema (DME): A Real‐life Study
Acta Ophthalmologica
Medicine
Ophthalmology
Outcomes in Diabetic Macular Edema Switched Directly or After a Dexamethasone Implant to a Fluocinolone Acetonide Intravitreal Implant Following Anti-Vegf Treatment
Acta Diabetologica
Internal Medicine
Medicine
Diabetes
Metabolism
Endocrinology
Efficacy and Safety of Sustained-Delivery Fluocinolone Acetonide Intravitreal Implant in Patients With Chronic Diabetic Macular Edema Insufficiently Responsive to Available Therapies: A Real-Life Study
Clinical Ophthalmology
Ophthalmology
Three-Year Results From the Retro-Ideal Study: Real-World Data From Diabetic Macular Edema (DME) Patients Treated With ILUVIEN® (0.19 Mg Fluocinolone Acetonide Implant)
European Journal of Ophthalmology
Medicine
Ophthalmology
Fluocinolone Acetonide (0.19 Mg) Intravitreal Implant Reduces Treatment Burden and Improves Practice Resource Utilisation for Patients With Diabetic Macular Oedema
BMJ Open Ophthalmology
Ophthalmology
Dexamethasone Implant in Diabetic Macular Edema
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Pharmacokinetic–Pharmacodynamic Modeling of the Effect of Triamcinolone Acetonide on Central Macular Thickness in Patients With Diabetic Macular Edema
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN®) in Patients With Diabetic Macular Edema: 10 Eyes With 12 Months Follow-Up
Ophthalmology and Therapy
Ophthalmology
